Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

11 Results
Structure: Internal structure identifier : 477909
Image document

Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib

Phillippe Saiag , Caroline Robert , Jean Jacques Grob , Laurent Mortier , Olivier Dereure , et al.
European Journal of Cancer, 2021, 154, pp.57-65. ⟨10.1016/j.ejca.2021.05.031⟩
Journal articles hal-03401780v1
Image document

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.

Bernard Escudier , Thierry Dorval , Nathalie Chaput , Fabrice André , Marie-Pierre Caby , et al.
J Transl Med, 2005, 3, pp.10. ⟨10.1186/1479-5876-3-10⟩
Journal articles inserm-00092539v1

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.

Cédric Ménard , Jean-Yves Blay , Christophe Borg , Stefan Michiels , François Ghiringhelli , et al.
Cancer Research, 2009, 69 (8), pp.3563-9. ⟨10.1158/0008-5472.CAN-08-3807⟩
Journal articles inserm-00484764v1

Breast cancer following radiotherapy for a hemangioma during childhood.

Nadia Haddy , Marie-Gabrielle Dondon , Catherine Paoletti , Carole Rubino , Abdeddahir Mousannif , et al.
Cancer Causes and Control, 2010, 21 (11), pp.1807-16. ⟨10.1007/s10552-010-9607-5⟩
Journal articles istex inserm-00609937v1
Image document

Estimating causal effects of time-dependent exposures on a binary endpoint in a high-dimensional setting

Vahé Asvatourian , Clélia Coutzac , Nathalie Chaput , Caroline Robert , Stefan Michiels , et al.
BMC Medical Research Methodology, 2018, 18 (1), pp.67. ⟨10.1186/s12874-018-0527-5⟩
Journal articles inserm-02310420v1
Image document

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1

Julien Rossignol , Zakia Belaid , Guillemette Fouquet , Flavia Guillem , Rachel Rignault , et al.
iScience, 2022, 25 (6), pp.104353. ⟨10.1016/j.isci.2022.104353⟩
Journal articles hal-03842485v1

Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy

Nadia Haddy , Tianarimanana Andriamboavonjy , Catherine Paoletti , Marie-Gabrielle Dondon , Abdeddahir Mousannif , et al.
Radiotherapy & Oncology, 2009, 93 (2), pp.377-82. ⟨10.1016/j.radonc.2009.05.011⟩
Journal articles istex inserm-00460601v1
Image document

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks

Michael Migden , Carmen Loquai , Caroline Robert , Jean- François Baurain , Nicholas Squittieri , et al.
Journal of The American Academy of Dermatology, 2022, Online ahead of print. ⟨10.1016/j.jdin.2022.08.027⟩
Journal articles inserm-03818996v1
Image document

Cancer mortality after radiotherapy for a skin hemangioma during childhood.

Marie-Gabrielle Dondon , Florent de Vathaire , Akhtar Shamsaldin , Françoise Doyon , Ibrahima Diallo , et al.
Radiotherapy & Oncology, 2004, 72, pp.87-93. ⟨10.1016/j.radonc.2004.03.011⟩
Journal articles inserm-00117150v1
Image document

Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering

Ana I Romero , Nathalie Chaput , Vichnou Poirier-Colame , Sylvie Rusakiewicz , Nicolas Jacquelot , et al.
Cancer Research, 2014, 74 (1), pp.68. ⟨10.1158/0008-5472.CAN-13-1186⟩
Journal articles inserm-02442721v1
Image document

Predictors of responses to immune checkpoint blockade in advanced melanoma

N. Jacquelot , M.P. Roberti , D.P. Enot , S. Rusakiewicz , N. Ternès , et al.
Nature Communications, 2017, 8 (1), pp.592. ⟨10.1038/s41467-017-00608-2⟩
Journal articles inserm-01824289v1